Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06528067 · ClinicalTrials.gov registry record · NA

Mindful Motivation for Reducing Binge Eating

A NA study of Health Behavior and Binge Eating, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06528067: Active NA study of Health Behavior and Binge Eating, sponsored by University of California, San Francisco.

NCT06528067 is a NA study of Health Behavior and Binge Eating that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06528067, a NA study of Health Behavior and Binge Eating, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to test how acceptable and feasible a new eating intervention is in people with overweight and binge eating. This intervention combines mindful eating with motivational interviewing to target binge eating. The main questions this clinical trial aims to answer are: How well do participants accept the new intervention (acceptability)? Is the intervention practical and easy to implement (feasibility)? In this trial researchers will compare the new eating intervention (motivational interviewing for mindful eating + digital meditation) to an active control (digital meditation) to see if the intervention can help reduce binge eating. Participants will: 1. Take online questionnaires at four different time points 2. Provide body composition and samples to measure glucose levels 3. Meditate for at least 10 minutes a day 4. If assigned to the Mindful Motivation group, 8 weeks of brief counseling

Primary Outcome

The Client Satisfaction Questionnaire (CSQ-8) has a total score scale range of 8 to 32, with higher numbers indicating greater satisfaction

Interventions

  • BEHAVIORAL Meditation
  • BEHAVIORAL Mindful Motivation

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-08-01
Est. Completion 2026-09-30
Phase NA

What the registry record for NCT06528067 still lists

NCT06528067 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (95% lower).

The record links to 4 conditions, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which Meditation is the first listed.

NCT06528067 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06528067 about?

NCT06528067 is a clinical study titled "Mindful Motivation for Reducing Binge Eating". The aim of this study is to test how acceptable and feasible a new eating intervention is in people with overweight and binge eating. This intervention combines mindful eating with motivational interviewing to target binge eating. The main questions this clinical trial aims to answer are: How well ...

What is the current status of trial NCT06528067?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-08-01. Estimated completion is 2026-09-30.

What conditions does trial NCT06528067 study?

This clinical trial studies the following conditions: Health Behavior, Binge Eating, Psychological, Weight, Body.

What interventions are being tested in trial NCT06528067?

The interventions under investigation include: Meditation (BEHAVIORAL), Mindful Motivation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06528067?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06528067 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06528067's enrollment target sits among peer trials

100 41st of 65 higher than 20 of 65 other Health Behavior trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06528067, the US trial registry maintained by the National Library of Medicine. NCT06528067 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.